Abstract
AbstractAs the world’s population is aging, sarcopenia is recognized as essential to assess people’s lifelong condition and do appropriate early intervention. Senile blepharoptosis is also a problem in old age deteriorating visual function and causing a cosmetic decline. We investigated the association between sarcopenia and the prevalence of senile blepharoptosis, using a nationwide representative survey in Korea. A total of 11,533 participants were recruited. We used the body mass index (BMI)- adjusted appendicular skeletal muscle (ASM) definition as the muscle mass index (MMI, ASM [kg] divided by BMI [kg/m2]). The association between blepharoptosis prevalence and MMI was analyzed using multivariate logistic regression. Sarcopenia, defined as the lowest MMI quintile group in both men and women, was also associated with the prevalence of blepharoptosis (ORs 1.92, 95% CI 1.17–2.16; p < 0.001). These associations remained statistically significant after adjusting for various factors related to blepharoptosis using multivariate analysis (ORs 1.18, 95% CI 1.04–1.34; p = 0.012). Moreover, MMI was found to have a proportional relationship with eyelid lifting force (levator function), which is closely related to the occurrence and severity of ptosis. Sarcopenia is related to the prevalence of senile blepharoptosis, and patients with lower MMI were more likely to have blepharoptosis. These results suggest that sarcopenia can affect visual function and aesthetics.
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. United Nations Department of Economic and Social Affairs, Population Division (2022). World population prospects 2022: Summary of Results. UN DESA/POP/2022/TR/NO. 3.
2. Sayer, A. A. et al. The developmental origins of sarcopenia. J. Nutr. Health Aging 12, 427–432. https://doi.org/10.1007/BF02982703 (2018).
3. Mijnarends, D. M. et al. Muscle, health and costs: A glance at their relationship. J. Nutr. Health Aging 22, 766–773. https://doi.org/10.1007/s12603-018-1058-9 (2018).
4. Rosenberg, I. H. Sarcopenia: Origins and clinical relevance. J. Nutr. 127, 990–991. https://doi.org/10.1093/jn/127.5.990S (1997).
5. Anker, S. D., Morley, J. E. & Haehling, S. V. Welcome to the ICD-10 code for sarcopenia. J. Cachexia Sarcopenia Muscle 7, 512–514. https://doi.org/10.1002/jcsm.12147 (2016).